Physician profile
Daniel E Goodrich
NPI 1538158209
$2,412.29
in general payments reported to CMS, 2019-2025
16 companies · $993 in 2025
The $993 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $355 · 2022: $331 · 2023: $221 · 2024: $512 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $489.21 | 2021-2024 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.35 | 2022-2025 | Jardiance |
| Abbvie INC. | $224.18 | 2021-2024 | |
| Novo Nordisk INC | $197.57 | 2024-2025 | Ozempic |
| Genzyme Corporation | $128.95 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $126.36 | 2025 | Airsupra |
| Kowa Pharmaceuticals America, INC. | $122.28 | 2025 | Zoryve |
| Axsome Therapeutics, INC. | $120.86 | 2025 | Auvelity |
| Amgen INC. | $120.53 | 2025 | Evenity |
| Neurelis, INC. | $118.34 | 2025 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $115.84 | 2021 | |
| Edwards Lifesciences Corporation | $112.33 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $96.00 | 2023 | Gattex |
| Bayer Healthcare Pharmaceuticals INC. | $54.20 | 2024 | |
| Depuy Synthes Sales INC. | $27.46 | 2025 | Tfn-Advance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $20.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Goodrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.